---
title: "Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $615,150"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292667722.md"
description: "Cytokinetics CEO Robert I. Blum disposed of 7,500 common shares for $615,150 on July 13, 2026, following the exercise of options for 7,490 shares at $10.60 per share. The transactions were conducted at an average price of $82.02 per share. Following these activities, Blum directly holds 377,820 shares in the company."
datetime: "2026-07-14T19:35:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292667722.md)
  - [en](https://longbridge.com/en/news/292667722.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292667722.md)
generator: "portal-rs"
---

# Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $615,150

-   Cytokinetics President and CEO Robert I. Blum reported stock sales tied to an option exercise on July 13, 2026. \* Disposed of 7,500 shares at USD 82.02. \* Exercised options for 7,490 shares at USD 10.6. \* Directly held 377,820 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytokinetics Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001061983-26-000077), on July 14, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CYTK.US](https://longbridge.com/en/quote/CYTK.US.md)

## Related News & Research

- [Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares for $265,370](https://longbridge.com/en/news/296267986.md)
- [Top Cytokinetics Executive Makes Attention-Grabbing Move With Insider Stock Sale](https://longbridge.com/en/news/296290252.md)
- [Cytokinetics grants new-hire equity awards, stock options priced at $74.13 per share](https://longbridge.com/en/news/296264145.md)
- [Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $575,700](https://longbridge.com/en/news/295452544.md)
- [Cytokinetics CEO Robert I. Blum disposes of 7,500 common shares for $606,525](https://longbridge.com/en/news/293972048.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**